Skip to main content

Advertisement

Log in

Low-dose total body irradiation: an overlooked cancer immunotherapy technique

  • Review
  • Published:
Journal of Radiation Oncology

Abstract

Low-dose total body irradiation (LD-TBI) has been shown to be an effective therapy for patients with hematologic malignancies. The application of this method has fallen out of favor as newer systemic therapies have been developed. Nevertheless, for management of many of these hematologic malignancies, no prospective randomized trial has shown that any other treatment is unequivocally superior to LD-TBI. The precise mechanism of action is uncertain but it is believed by some to be at least partly immunologically mediated. In this review, we shall discuss the clinical data on this method along with some new potential applications. We also discuss some of the potential immunological mechanisms behind LD-TBI and consider future possibilities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Safwat A (2000) The immunobiology of low-dose total-body irradiation: more questions than answers. Radiat Res 153:599–604

    Article  CAS  PubMed  Google Scholar 

  2. Johnson RE (1966) Evaluation of fractionated total-body irradiation in patients with leukemia and disseminated lymphomas. Radiology 86:1085–1089

    Article  CAS  PubMed  Google Scholar 

  3. Qasim MM (1979) Total body irradiation as a primary therapy in non-Hodgkin lymphoma. Clin Radiol 30:287–286

    Article  CAS  PubMed  Google Scholar 

  4. Chaffey JT, Rosenthal DS, Pinkus F, Hellman S (1975) Advanced lymphosarcoma treated by total body irradiation. Br J Cancer 31(SUPPL 2):441–449

    Google Scholar 

  5. Hoppe RT, Kushlan P, Kaplan HS, Rosenberg SA, Brown BW (1981) The treatment of advanced stage favorable histology non-Hodgkin’s lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood 58:592–598

    CAS  PubMed  Google Scholar 

  6. Wang B, Li B, Dai Z et al (2014) Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells. Int J Biochem Cell Biol 55:98–108

    Article  CAS  PubMed  Google Scholar 

  7. Dreyling M, Ghielmini M, Marcus R et al (2011) Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 22:vi59–vi63

    Article  PubMed  Google Scholar 

  8. Lowry L, Smith P, Qian W et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 100:86–92

    Article  PubMed  Google Scholar 

  9. Kamstrup MR, Gniadecki R, Iversen L et al (2015) Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis. Int J Radiat Oncol Biol Phys 92(1):138–143

    Article  PubMed  Google Scholar 

  10. Hoppe RT, Harrison C, Tavallaee M et al (2015) Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol 72(2):286–292

    Article  PubMed  Google Scholar 

  11. Haas RL (2009) Low dose radiotherapy in indolent lymphomas, enough is enough. Hematol Oncol 27(2):71–81

    Article  CAS  PubMed  Google Scholar 

  12. Ganem G, Cartron G, Girinsky T, Haas RL, Cosset JM, Solal-Celigny P (2010) Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks. Int J Radiat Oncol Biol Phys 78(4):975–982

    Article  PubMed  Google Scholar 

  13. Ganem G, Lambin P, Socié G et al (1994) Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin’s lymphomas. Hematol Oncol 12(1):1–8

    Article  CAS  PubMed  Google Scholar 

  14. Girinsky T, Paumier A, Ferme C et al (2012) Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients. Int J Radiat Oncol Biol Phys 83(3):e385–e389

    Article  PubMed  Google Scholar 

  15. Choi NC, Timothy AR, Kaufman SD, Carey RW, Aisenberg AC (1979) Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Cancer 43:1636–1642

    Article  CAS  PubMed  Google Scholar 

  16. Safwat A, Bayoumy Y, El-Sharkawy N, Shaaban K, Mansour O, Kamel A (2003) The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemoresistant non-Hodgkin’s lymphoma. Radiother Oncol 69:33–36

    Article  PubMed  Google Scholar 

  17. Cuttler JM, Pollycove M (2003) Can cancer be treated with low doses of radiation? J Am Phys Surg 8:108–111

    Google Scholar 

  18. Oakley PA (2015) Is use of radiation Hormesis the missing link to a better cancer treatment? Journal of Cancer Therapy 6:601–605

    Article  Google Scholar 

  19. Song KH, Kim MH, Kang SM et al (2015) Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. Int J Radiat Biol 23:1–9 [Epub ahead of print]

    CAS  Google Scholar 

  20. Bayoumi Y, Radwan A (2015) Low dose total body irradiation for relapsed low grade non-Hodgkin’s lymphoma: experience of National Cancer Institute, Cairo. Journal of Cancer Therapy 6:25–33

    Article  Google Scholar 

  21. Cao M, Cabrera R, Xu Y, Liu C, Nelson D (2011) Different radiosensitivity of CD4+CD25+ regulatory T cells and effector T cells to low dose gamma irradiation in vitro. Int J Radiat Biol 87(1):71–80

    Article  CAS  PubMed  Google Scholar 

  22. Welsh JS (2004) Waldenstrom’s Macroglobulinemia treated with fractionated low-dose total body irradiation. Case Rep Clin Pract Rev 5:CS425–CS431

    Google Scholar 

  23. Chaffey JT, Rosenthal DS, Moloney WC, Hellman S (1976) Total body irradiation as treatment for lymphosarcoma. Int J Radiat Oncol Biol Phys 1(5–6):399–405

    Article  CAS  PubMed  Google Scholar 

  24. Brereton HD, Young RC, Longo DL et al (1979) A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin’s lymphoma. Cancer 43:2227–2231

    Article  CAS  PubMed  Google Scholar 

  25. Anonymous (1981) British National Lymphoma Investigation Report: a prospective comparison of combination chemotherapy with total body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Clin Oncol 7:193–200

    Google Scholar 

  26. Meerwaldt JH, Carde P, Burgers JM et al (1991) Low dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. Int J Radiat Oncol Biol Phys 21:1167–1172

    Article  CAS  PubMed  Google Scholar 

  27. Weick JK, Antunez A, Kraus TA (1983) The combined modality therapy of diffuse histology non-Hodgkin’s lymphoma with CHOP and total body irradiation. Int J Radiat Oncol Biol Phys 9:1205–1207

    Article  CAS  PubMed  Google Scholar 

  28. Richaud PM, Soubeyran P, Eghbali H et al (1998) Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin’s lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 40(2):387–390

    Article  CAS  PubMed  Google Scholar 

  29. Johnson RE, Canellos GP, Young RC, Chabner BA, DeVita VT (1978) Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep 62:321–325

    CAS  PubMed  Google Scholar 

  30. Travis LB, Weeks J, Curtis RE et al (1996) Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin’s lymphoma. J Clin Oncol 14:565–571

    Article  CAS  PubMed  Google Scholar 

  31. Ellis M, Lishner M (1993) Second malignancies following treatment in non-Hodgkin’s lymphoma. Leuk Lymphoma 9:337–342

    Article  CAS  PubMed  Google Scholar 

  32. Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C (1998) Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 124(3–4):207–214

    Article  CAS  PubMed  Google Scholar 

  33. Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O (2012) Second malignancies after multiple myeloma: from 1960s to 2010s. Blood 119(12):2731–2737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91:4–15

    Article  PubMed  Google Scholar 

  35. Mendenhall NP, Noyes WD, Million RR (1989) Total body irradiation for stage II-IV non-Hodgkin’s lymphoma: ten-year follow-up. J Clin Oncol 7:67–74

    Article  CAS  PubMed  Google Scholar 

  36. Dobbs HJ, Barrett A, Rostom AY et al (1981) Total body irradiation in advanced non-Hodgkin’s lymphoma. Br J Radiol 54:878–881

    Article  CAS  PubMed  Google Scholar 

  37. Lybeert ML, Meerwaldt JH, Deneve W (1987) Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 13:1167–1172

    Article  CAS  PubMed  Google Scholar 

  38. Fourquet A, Teillaud JL, Lando D et al (1993) Effects of low dose total body irradiation and recombinant human interlukin-2 in mice. Radiother Oncol 26:219–225

    Article  CAS  PubMed  Google Scholar 

  39. Yonkosky DM, Feldman MI, Cathcart ES, Kim S (1978) Improvement of in-vitro mitogen proliferative responses in non-Hodgkin’s lymphoma patients exposed to fractionated total body irradiation. Cancer 42:1204–1210

    Article  CAS  PubMed  Google Scholar 

  40. Safwat A (2000) The role of low-dose total body irradiation in treatment of NHL: a new look at an old method. Radiother Oncol 56:1–8

    Article  CAS  PubMed  Google Scholar 

  41. Pollycove M (2007) Radiobiological basis of low-dose irradiation in prevention and therapy of cancer. Dose-Response 5(1):26–38

    Article  CAS  Google Scholar 

  42. Nowosielska EM, Cheda A, Wrembel-Wargocka J, Janiak MK (2010) Immunological mechanism of the low-dose radiation-induced suppression of cancer metastases in a mouse model. Dose Response 8(2):209–226

    Article  CAS  Google Scholar 

  43. Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M (2003) Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma. J Exp Ther Oncol 3:161–168

    Article  CAS  PubMed  Google Scholar 

  44. Hosoi Y, Sakamoto K (1993) Suppressive effect of low dose total body irradiation on lung metastasis: dose dependency and effective period. Radiother Oncol 26:177–179

    Article  CAS  PubMed  Google Scholar 

  45. Hosoi Y (2006) Antitumor effects by low dose total body irradiation. [Article in Japanese with English abstract] Yakugaku Zasshi 126(10):841–848

    Article  CAS  PubMed  Google Scholar 

  46. Safwat A, Schmidt H, Bastholt L et al (2005) A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma. Radiother Oncol 77:143–147

    Article  CAS  PubMed  Google Scholar 

  47. Sakamoto K, Myogin M, Hosoi Y (1997) Fundamental and clinical studies on cancer control with total or upper half body irradiation. J Jpn Soc Ther Radiol Oncol 16:161–175

    Google Scholar 

  48. Song KH, Kim MH, Kang SM et al (2015) Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. Int J Radiat Biol 91(10):795–803

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James S. Welsh.

Ethics declarations

Funding

No funding was received for this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Statement of informed consent was not applicable since the manuscript does not contain any patient data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Block, A.M., Silva, S.R. & Welsh, J.S. Low-dose total body irradiation: an overlooked cancer immunotherapy technique. J Radiat Oncol 6, 109–115 (2017). https://doi.org/10.1007/s13566-017-0303-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-017-0303-x

Keywords

Navigation